Form 8-K PharMerica CORP For: Feb 26

Go back to Form 8-K PharMerica CORP For: Feb 26

Pharmerica (PMC) Tops Q4 EPS by 4c; Guides FY16 EPS Below Expectations

February 26, 2016 8:06 AM EST

Pharmerica (NYSE: PMC) reported Q4 EPS of $0.45, $0.04 better than the analyst estimate of $0.41. Revenue for the quarter came in at $520.6 million versus the consensus estimate of $506.4 million.

GUIDANCE:

Pharmerica sees FY2016 EPS of $1.95-$2.05, versus the consensus of $2.31. Pharmerica sees FY2016... More